Endothelialized microfluidic assays for emerging therapies in sickle cell disease

$842,828R42FY2023HLNIH

Biochip Labs, Inc., Cleveland OH

Investigators

Chiara Federicicontact Umut A. Gurkan

Linked publications & trials

Paper 39152149 Paper 38329864 Paper 37873474 Paper 37424286 Paper 36652689 Paper 36649586 Paper 36521205 Paper 35916533

View original record on NIH RePORTER →